• Health & Medicine

Testing a new immunotherapy treatment for neuroblastoma

A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma. A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.

3 May 2017

• Science & Technology

This could be the future of how doctors view cancer

Step inside a virtual world where our Grand Challenge scientists are hoping to redefine the way we look at cancer. Step inside a virtual world where our Grand Challenge scientists are hoping to redefine the way we look at cancer.

2 May 2017

• Health & Medicine

Experimental blood test could offer a glimpse of the future for doctors treating lung cancer

An experimental blood test could offer a way to detect early signs that patients’ lung cancers will return after treatment. An experimental blood test could offer a way to detect early signs that patients’ lung cancers will return after treatment.

26 April 2017

• Science & Technology

Tracing genetic chaos in 100 lung cancer patients could help predict survival

By tracing genetic chaos over time our scientists may have found a way to help predict lung cancer survival. By tracing genetic chaos over time our scientists may have found a way to help predict lung cancer survival.

26 April 2017

• Science & Technology
• Health & Medicine

Tracking unstable chromosomes helps predict lung cancer’s return

The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse. The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse.

26 April 2017

• Health & Medicine

CRISPR genome editing and immunotherapy – the early adopter

How is CRISPR genome editing helping harness the power of immunotherapy? How is CRISPR genome editing helping harness the power of immunotherapy?

21 April 2017

• Science & Technology
• Health & Medicine

Taking advantage of cancers’ abnormal metabolism could lead to a new way to ‘starve’ tumours

Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet. Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet.

19 April 2017

• Science & Technology

Amino acids in diet could be key to starving cancer

Cutting out certain amino acids – the building blocks of proteins – from the diet of mice slows tumour growth and prolongs survival. Cutting out certain amino acids – the building blocks of proteins – from the diet of mice slows tumour growth and prolongs survival.

19 April 2017

• Science & Technology

CRT pioneer fund, Cancer Research UK and NCI collaborate to boost research against the ‘undruggable’ RAS

Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute. Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute.

19 April 2017

• Science & Technology

Targeting cancer spread: keeping breast tumours under LOX and key

Find out how our scientists are developing a way to target a troublesome cancer molecule, LOX. Find out how our scientists are developing a way to target a troublesome cancer molecule, LOX.

18 April 2017

• Science & Technology
• Health & Medicine

News digest – immunotherapies showing promise, breast cancer drug approved for Scotland, childhood cancer rates, and… killer sofas?

Immunotherapies show promise but not for every tumour, calls for boys to get the HPV vaccine and... what's killer about sofas? Find out in the news digest. Immunotherapies show promise but not for every tumour, calls for boys to get the HPV vaccine and... what's killer about sofas? Find out in the news digest.

14 April 2017

• Science & Technology

Cancer living outside the body, unravelling a cellular mystery and targeting ‘sleeping’ cancer cells: our latest cutting-edge science projects

Our rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund. Our rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund.

14 April 2017